A new paradigm evaluating cost per cure of HCV infection in the UK
Crossref DOI link: https://doi.org/10.1186/s41124-016-0002-z
Published Online: 2016-04-14
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Barclay, Stephen T.
,
Cooke, Graham S.
Holtham, Elizabeth
Gauthier, Aline
Schwarzbard, Jeremie
Atanasov, Petar
Irving, William L.
Funding for this research was provided by:
Gilead Sciences (US)